Operating signal within 12 months from two or more independent sources.
What they make
Pharmaceutical Preparation Manufacturing325412Grifols develops, produces, and markets medicines, solutions, and services in the biopharma, diagnostic, bio supplies, and healthcare solutions sectors, serving hospitals and operating in more than 110 countries. The company works across multiple therapeutic areas including immunology, hepatology and intensive care, pulmonology, hematology, neurology, and infectious diseases.
SUMMARIZED FROM THE COMPANY’S OWN WEBSITE
Products
Recorded against the company rather than this address. Federal award and drug records name the company, not the plant, so we cannot say which of its sites makes these.
Where these came from
Where it is
Location not verified — this address could not be matched to Census TIGER, so the facility is not placed on the map.
Other plants nearby
No other listed facility within 40 km shares this one’s four-digit industry code, or this record has no coordinates to measure from.
Also at this address
No other federal record shares this street address.
WHERE THIS RECORD COMES FROM — 2 FEDERAL SOURCES, 7 FIELDS
Every fact on this page traces to a public federal filing. The table below names which register holds this facility, whether that register proves the plant operates or only that it exists, and when each of them last saw it.
| Source | Evidence | First seen | Last seen |
|---|---|---|---|
| COMPANY SITE | OPERATING | JUL 2026 | AUG 2026 |
| SAM GOV | OPERATING | JUN 2026 | JUN 2026 |
FIELD BY FIELD — WHICH SOURCE SUPPLIED WHAT
| FIELD | SOURCE | SIGNAL |
|---|---|---|
| ADDRESS LINE1 | SAM GOV | JUN 2026 |
| CAGE CODE | SAM GOV | JUN 2026 |
| CITY | SAM GOV | JUN 2026 |
| NAME | SAM GOV | JUN 2026 |
| REGISTRATION EXPIRATION | SAM GOV | JUN 2026 |
| STATE | SAM GOV | JUN 2026 |
| WEBSITE | SAM GOV | JUN 2026 |
Status is computed from independent sources; nothing here is self-reported unless marked Claimed.